Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Buffers and Standards
  4. Chromatography Standards
  5. Drug Standards
  6. B0631ML

Brivaracetam-D3 solution, 100 μg/mL in methanol, certified reference material, ampule of 1 mL, Cerilliant

Catalog No. B0631ML Shop All MilliporeSigma Products
Change view
Click to view available options
Quantity:
1 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
B0631ML 1 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. B0631ML Supplier MilliporeSigma Supplier No. B0631ML
Only null left
Add to Cart
Add to Cart

Description

An internal standard suitable for GC/MS or LC/MS applications in brivaracetam testing from clinical toxicology and forensic analysis to urine drug testing and isotope dilution methods.

An internal standard suitable for GC/MS or LC/MS applications in brivaracetam testing from clinical toxicology and forensic analysis to urine drug testing and isotope dilution methods. Brivaracetam is an antiepileptic drug for the treatment of partial-onset seizures. The drug is marketed under the trade name Briviact.

TRUSTED_SUSTAINABILITY

Specifications

Chemical Name or Material Brivaracetam-D3
Packaging Ampule of 1 mL
Molecular Formula C11H17D3N2O2
Concentration 100 μg/mL in Methanol
For Use With (Equipment) Gas Chromatography (GC), Liquid Chromatography (LC)
Solution Type Standard Solution
Type Certified Reference Material
Industry Type Forensics, Toxicology
Molecular Weight (g/mol) 215.31
Quantity 1 mL
Grade Certified
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.